Skip to content

Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan

The Clinical Performance of the Silicone Hydrogel Contact Lens on Low to Moderate Astigmatism in Japan

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00639353
Enrollment
102
Registered
2008-03-20
Start date
2008-02-29
Completion date
Unknown
Last updated
2014-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia, Refractive Error

Brief summary

This study seeks to evaluate the clinical performance of a recently released contact lens designed to correct astigmatism to an established contact lens that has historically been used in these patients.

Interventions

DEVICEsenofilcon A toric soft contact lens

contact lens

DEVICEsenofilcon A sphere soft contact lens

contact lens

Sponsors

Johnson & Johnson
CollaboratorINDUSTRY
Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

1. The subject is 18 to 39 years of age. (Parental consent is required for a minor child i.e. under the age of 20.) 2. The subject has signed an informed consent with his/her own judgement for participation in the study. 3. The subject currently is a habitual wearer of spherical or toric daily-wear soft contact lenses, excluding daily disposables, in daily wear bases.

Exclusion criteria

1. The subject has any ocular or systemic allergies that interfere with contact lens wear. 2. The subject has dry eye and lacrimal apparatus disease that could interfere with contact lens wear. 3. The subject has any systemic disease or autoimmune disease that interferes with contact lens wear. 4. The subject has corneal edema, neovascularization, corneal staining or other ocular abnormalities (Grade 3 or above) that clinically apparently interfere with contact lens wear. 5. The subject has any anterior segment eye disease (palpebral abnormalities, corneal hypesthesia, corneal epithelial defect, bulbar conjunctival hyperemia, etc.) that clinically apparently interferes with contact lens wear. 6. The subject has a history of solution reactions to the chemical cleaner/disinfectant to be used in this study, as far as known to the subject. 7. The subject has ocular infection. 8. The subject has ocular inflammation (including acute/subacute anterior segment inflammations and uveitis). 9. The subject has corneal distortion resulting from previous experience of hard contact lens wear. 10. The subject has infectious disease (pneumonia, tuberculosis, etc.) or immunosuppressive disease (HIV positive etc.), as far as known to the subject. 11. The subject has diabetes, as far as known to the subject. 12. The subject is pregnant or in the lactation period, as far as known to the subject. 13. The subject uses any eye remedies (excluding artificial tear substitutes or hyaluronic acid drops for reducing dryness while wearing contact lenses). 14. The subject had any ocular trauma or surgery within 8 weeks prior to participation in the study. 15. The subject is a wearer of hard contact lenses (including rigid gas permeable). 16. The subject is exposed to a dry environment on a constant basis. 17. The subject is exposed to a living environment where dust, chemicals, etc. can easily enter the eye. 18. The subject is unable to follow the principal investigator's instructions. 19. The subject is unable to follow lens hygiene procedures necessary for contact lens wear.

Design outcomes

Primary

MeasureTime frameDescription
Subject-reported satisfaction for visionAfter 2 weeks of lens wearScale of 0 to 100, were 0=extremely poor and 100=Excellent
Subject-reported satisfaction for comfort.After 2 weeks of lens wearScale of 0 to 100, were 0=extremely poor and 100=Excellent

Secondary

MeasureTime frame
Subject preference for lens type.After 2 weeks of lens wear.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026